State to receive $35M from settlement with Pfizer
Published: August 11,2014
Tags: Attorney General's Office, court, drug, Jim Hood, justice, lawsuit, medical, medicine, organ transplant, Pfizer Inc. health care, pharmaceutical, Rapamune, settlement, State of Mississippi, Wyeth Pharmaceuticals Inc.
JACKSON — Mississippi will receive $532,675 part of a $35 million settlement with a Pfizer Inc. subsidiary over the marketing of an organ-transplant drug.
Mississippi and 41 other states are involved in the settlement with Pfizer, the parent company of Wyeth Pharmaceuticals Inc. The deal resolves allegations Wyeth misrepresented the uses of the drug Rapamune.
A statement from Mississippi Attorney General Jim Hood says “state consumer protection laws were violated by misrepresentation of the uses and benefits of Rapamune.”
Rapamune was approved to help prevent the rejection of kidney transplants. The states alleged the company promoted it to doctors for uses following other organ transplants.
New York-based Pfizer says in a statement the alleged activity occurred before it acquired Wyeth. Pfizer didn’t admit wrongdoing or liability as part of the settlement.
To sign up for Mississippi Business Daily Updates, click here.
Top Posts & Pages
- (UPDATE) Prison won’t interrupt ex-prison chief’s retirement cash flow
- JOSH MABUS — Inbound marketing is fueled by wishful thinking
- Kemper plant employee gag order continued
- 2014 a good year for filmmaking in Mississippi
- Nehi Bottling Company has been a Cleveland fixture for 85 years
- WRESTLING SUCCESS — Ted DiBiase Jr. leaves ring to become entrepreneur
- MARTIN WILLOUGHBY — Doug Dale’s self-awareness helps lift him to top of his game
- Ex-prison boss and businessman admit to bribery scheme
- (UPDATED — BREAKING NEWS) American Specialty Alloys won’t locate $1.2B mill in Mississippi